Breadcrumb
Investigadores - Título

Investigación - Nuestro equipo

PeopleCategories
People
Bàrbara Baro

Bàrbara Baro

Assistant Research Professor

Bàrbara Baro graduated in Biotechnology at Universitat Autònoma de Barcelona in 2007. She obtained her PhD in Biomedicine at Universitat de Barcelona in 2013, working on the molecular regulation of mitosis at the laboratory of Dr. Ethel Queralt (Institut d'Investigació Biomèdica de Bellvitge), under an FPU fellowship.

In 2014, she joined Dr. Marcus Lacerda’s group at the Tropical Medicine Foundation Dr.Heitor Vieira Dourado (Manaus, Brazil), where she worked on malaria vivax as a FAPEAM postdoctoral fellow, studying the parasites found in the bone marrow during natural infections and their impact on erythropoiesis. In 2016, she continued her postdoctoral training at Stanford University (USA), at the laboratory of Dr. Elizabeth Egan, where she worked on new host-parasite interactions during Plasmodium falciparum infection, under a fellowship of the Stanford Child Health Research Institute.

In 2018, she joined ISGlobal as a Beatriu de Pinós fellow to coordinate the field work of a malaria control and elimination program in Lihir Islands (Papua New Guinea), in collaboration with the PNG Institute of Medical Research. During the pandemic, she actively participated in researching the epidemiology, diagnostics, and treatment of COVID-19 in collaboration with several hospitals of Barcelona.

In 2023, she was appointed Assistant Research Professor at ISGlobal, where she currently leads a research group focused on decreasing the burden and impact of severe infections. 

Líneas de investigación

  • Molecular mechanisms underlying severe infections and biomarker discovery for enhanced management. 
  • Novel point-of-care tools for improved diagnostics and risk stratification of infections.
  • Novel management strategies and treatments to prevent severe outcomes during infection. 

Principales publicaciones

  • Alemany A, Balanza N, Millat-Martinez P, Ouchi D, Corbacho-Monné M, Morales-Indiano C, Fernández Rivas G, Blanco I, Mitjà O, Aguilar R, Dobaño C, Bassat Q, Moncunill G, Baro B. Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study. Frontiers in Immunology 2024; 15
  • Millat-Martínez P, Katusele M, Kasian B, Omera E, Jamea E, Lorry L, Casellas A, Ouchi D, Wali C, Raulo S, Elizah A, Kaman P, Dau A, Sakur M, Kilepak L, Yabu S, Koata N, Kave J, Toa M, Urakusie C, Kongs C, Kisba F, Laman M, Mitjà O, Pomat W, Bassat Q, Karl S, Baro B. Human and entomological determinants of malaria transmission in the Lihir Islands of Papua New Guinea: A cross-sectional study. PLOS Neglected Tropical Diseases 2025; 19(1): e0012277
  • Baro B, Rodo P, Ouchi D, Bordoy AE, Saya Amaro EN, Salsench SV, Molinos S, Alemany A, Ubals M, Corbacho-Monné M, Millat-Martinez P, Marks M, Clotet B, Prat N, Estrada O, Vilar M, Ara J, Vall-Mayans M, G-beiras C, Bassat Q, Blanco I, Mitjà O. Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison. Journal of Infection 2021; 82(6): 269-75.
  • Baro B, Kim CY, Lin C, Kongsomboonvech AK, Tetard M, Peterson NA, Salinas ND, Tolia NH, Egan ES. Plasmodium falciparum exploits CD44 as a coreceptor for erythrocyte invasion. Blood 2023; 142(23): 2016-28
  • Brito MAM*, Baro B*, Raiol TC, Ayllon-Hermida A, Safe IP, Deroost K, Figueiredo EFG, Costa AG, Armengol MDP, Sumoy L, Almeida ACG, Hounkpe BW, de Paula, EV, Fernandez-Becerra C, Monteiro WM, del Portillo HA,  Lacerda MVG. Morphological and Transcriptional Changes in Human Bone Marrow During Natural Plasmodium vivax Malaria Infections. The Journal of Infectious Diseases 2022; 225(7): 1274-83  
Publicador de contenidos